Generics utilization policies necessary to sustain Medicaid

posted 27/03/2015

A review of the history and expansion of generics utilization policies and their critical role in the US Medicaid system in an era of reduced budgets conclud...

Paying physicians to prescribe generics and bio... Biosimilars/Research | Posted 27/03/2015
US court rejects Amgen’s bid to block filgrasti... Biosimilars/News | Posted 27/03/2015
Drug manufacturers call for revision to FDA saf... Policies & Legislation | Posted 27/03/2015
Rheumatologists want to evaluate long-term safe... Biosimilars/General | Posted 27/03/2015
Actavis loses Atelvia patents Generics/News | Posted 27/03/2015
Survey among pharmacists shows high confidence... Biosimilars/Research | Posted 20/03/2015
Biosimilars of filgrastim Biosimilars/General | Posted 20/03/2015
Health Canada clamps down on GMP compliance Generics/General | Posted 20/03/2015
Infliximab biosimilars tighten grip on European... Biosimilars/News | Posted 20/03/2015
California and Illinois consider biosimilar sub... Policies & Legislation | Posted 20/03/2015
Ranbaxy fails to reverse FDA decision over Valc... Generics/News | Posted 20/03/2015
FDA approves its first biosimilar Biosimilars/News | Posted 13/03/2015
Equivalent safety and efficacy of nephrology su... Biosimilars/Research | Posted 13/03/2015
Potential savings of Euros 72 million with more... Generics/Research | Posted 13/03/2015
Huge discount on biosimilar infliximab in Norway Biosimilars/General | Posted 13/03/2015
Mexico issues rules on biolimbos Guidelines | Posted 13/03/2015
Drug companies seek to block generic version of... Generics/News | Posted 13/03/2015
Second Apotex biosimilar under FDA review Biosimilars/News | Posted 13/03/2015
What happened in biosimilars during 2014 Biosimilars/General | Posted 06/03/2015
Poor generics awareness among physicians in Sau... Generics/Research | Posted 06/03/2015
Hospira launches infliximab biosimilar in major... Biosimilars/News | Posted 06/03/2015
EMA’s clinical transparency rules come under fire Policies & Legislation | Posted 06/03/2015
FDA cash to develop hard-to-copy generics Generics/General | Posted 06/03/2015
Comparison of non-originator filgrastim with Ne... Biosimilars/Research | Posted 06/03/2015
US court invalidates asthma drug patent Generics/News | Posted 06/03/2015
FDA delays meeting to evaluate infliximab biosi... Biosimilars/News | Posted 27/02/2015
Biosimilars of rituximab Biosimilars/General | Posted 27/02/2015
Pfizer warns UK doctors not to prescribe generi... Generics/General | Posted 27/02/2015
FDA re-opens comment period on generics labelli... Policies & Legislation | Posted 27/02/2015
Accord launches biosimilar filgrastim in Europe Biosimilars/News | Posted 27/02/2015
Actavis receives generic opioid approval and pl... Generics/News | Posted 27/02/2015
World Biosimilar Congress USA 2015 Conferences | Posted 27/02/2015
Generics and off-patent biologicals for cancer... Biosimilars/Research | Posted 20/02/2015
Substitution and adherence to antidiabetic gene... Generics/Research | Posted 20/02/2015
Positive phase III data for Amgen adalimumab bi... Biosimilars/Research | Posted 20/02/2015
Hospira and Pfenex to collaborate on ranibizuma... Biosimilars/News | Posted 20/02/2015
Mylan being sued over sorafenib generic Generics/News | Posted 20/02/2015
Biosimilars compared to generics in the Europea... Biosimilars/Research | Posted 13/02/2015

Generics News Research General


Biosimilars News Research General